accessory |
, in relation to a medical device covered by paragraph 41BD(1)(a), (aa) or (ab), means a thing that the manufacturer of the thing specifically intended to be used together with the device to enable the device to be used as the manufacturer of the device intended.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41BD What is a medical device
Therapeutic Goods Act 1989 - 3 Interpretation
|
actual or potential tampering |
has the meaning given by section 42U.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 42U Meaning of actual or potential tampering etc.
Therapeutic Goods Act 1989 - 3 Interpretation
|
advertise |
, in relation to therapeutic goods, includes make any statement, pictorial representation or design that is intended, whether directly or indirectly, to promote the use or supply of the goods, including where the statement, pictorial representation or design:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
anthroposophic pharmacopoeia |
means:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3AB Anthroposophic preparations and anthroposophic standards
Therapeutic Goods Act 1989 - 3 Interpretation
|
anthroposophic preparation |
has the meaning given by subsection 3AB(1).
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3AB Anthroposophic preparations and anthroposophic standards
Therapeutic Goods Act 1989 - 3 Interpretation
|
anthroposophic standard |
has the meaning given by subsection 3AB(2).
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3AB Anthroposophic preparations and anthroposophic standards
Therapeutic Goods Act 1989 - 3 Interpretation
|
applicant |
means an applicant for approval of the use of a restricted representation in an advertisement about therapeutic goods.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 42DB Definitions
|
application audit assessment fee |
means a fee payable under subsection 41LA(3).
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41LA Assessment fees
Therapeutic Goods Act 1989 - 3 Interpretation
|
approval holder |
, in relation to a restricted representation, means the person to whom notice of approval of the use of the restricted representation was given.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 42DB Definitions
|
assessment fee |
means:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
Australian conformity assessment body |
means an Australian corporation that is the subject of a conformity assessment body determination made under the regulations.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
Australian conformity assessment body certificate |
means a certificate that is issued by an Australian conformity assessment body and that is of a kind mentioned in section 41FIA.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41FIA Certificates issued by Australian conformity assessment bodies
Therapeutic Goods Act 1989 - 3 Interpretation
|
Australia‐UK Mutual Recognition Agreement |
means the Agreement on Mutual Recognition in Relation to Conformity Assessment, Certificates And Markings between the Government of Australia and the Government of the United Kingdom of Great Britain and Northern Ireland, as in force from time to time.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
batch |
means a quantity of a product that is:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
bioburden |
, in relation to therapeutic goods, means the quantity and characteristics of microorganisms present in the goods or to which the goods may be exposed in a manufacturing environment.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
biological |
has the meaning given by section 32A.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
Therapeutic Goods Act 1989 - 32A Meaning of biological
|
biological number |
of a biological means:
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 32DB Inclusion of Class 1 biological in the Register
Therapeutic Goods Act 1989 - 3 Interpretation
|
British Pharmacopoeia |
means the edition of the publication of that name, including any additions or amendments, that was in effect for the purposes of this Act immediately before the commencement of Schedule 4 to the Therapeutic Goods Amendment (Medical Devices and Other Measures) Act 2009 and, if additions or amendme |
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 3 Interpretation
|
certification‐related activities |
, when used in relation to an Australian conformity assessment body, means activities that consist of, or relate to, the issue of certificates as mentioned in section 41FIA.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 41FIA Certificates issued by Australian conformity assessment bodies
Therapeutic Goods Act 1989 - 3 Interpretation
|
civil penalty provision |
has the meaning given by section 42YA.
|
Therapeutic Goods Act 1989 |
Therapeutic Goods Act 1989 - 42YA What is a civil penalty provision ?
Therapeutic Goods Act 1989 - 3 Interpretation
|